Home | Press Room | Site Map | e-supply | Türkçe
sep

Manufacturing & Logistics

20,000 sqm of indoor production facility within an open area of 50,000 sqm, suitable for all forms of pharmaceuticals

sep General Information
Solid Manufacturing
Semi-Solid Manufacturing
Sterile Liquid Manufacturing
Non-Sterile Liquid Manufacturing
Injectable Cephalosporin
Oral Cephalosporin
Oral Penicillin
Weighing
Packaging
Materials Management

General Information

A‒  A+  print

Using environment-friendly technologies in its state-of-the-art processing facilities, PharmaVision produces ca. 102 million packs of pharmaceuticals per year, which is about 9,5% of the local pharmaceutical production. With its superior quality approach and high technological standards, PharmaVision produces pharmaceuticals also for international markets, the amount of which corresponds to about 15% of total pharmaceutical exports from Turkey.

Located on a 50,000 sqm campus, PharmaVision is well equipped to manufacture, in a cGMP-compliant fashion, the following pharmaceutical forms; including injectable cephalosporin, oral cephalosporin and oral penicillin group products, manufactured in dedicated, separate entities, completely independent from non beta-lactam manufacturing areas:

  • Tablets (dry granulation, wet granulation, direct compression, film coating and sugar coating)
  • Capsules and sachets 
  • Ampoules, vials for injection (sterile liquid and powder)
  • Syrups (liquid and powder), suspensions, solutions, drops and sprays
  • Creams, gels and ointments

(Please click here for more detailed information on manufacturing capabilities)

From weighing to finished good dispatch, closed, fully-automated and computerized systems in controlled areas are in place. All our packaging lines are individually equipped with track and trace systems (2D Data Matrix System); this service is being offered all the way from cartoning to palletizing processes.

While maintaining close control on product costs, Environment, Health and Safety standards are also complied with and most importantly product quality and regulatory compliance are regarded as the most important criteria. All manufacturing units are held responsible for the quality of their work throughout the life cycle of their respective products and are continuously asked to gauge and improve. With various performance indicators such as on-time delivery, plant cycle times, right the first time and safety records (e.g. number of accidents), it is ascertained that superior product quality, economical manufacturing costs, high safety and environmental standards and constant regulatory compliance can all be achieved concomitantly.

Top priority is given to reliable verification studies, including process, analytical method, cleaning and computerized manufacturing systems validations. Through a functional change control system, it is ensured that these validations remain intact throughout the lifecycle of the products manufactured in our facilities.

This commitment to quality is proven by consistently successful audits conducted by the Turkish Ministry of Health, AFSAPPS (French Health Products Safety Agency), PIC (Pharmaceutical Inspection Convention)Croatian Health Authority, Belarus Health Authority, Ucrain Health Authority and the audit divisions of several leading multinationals, for whom we manufacture in toll.

In addition to adhering to cGMP-related quality criteria, our site became the pioneer among all Hoechst Marion Roussel (PharmaVision’s predecessor) facilities to obtain the TS EN ISO 14001 Environmental Management System Certificate in 1998; furthermore with the renewal of the present BS 8800 Occupational Health and Safety Certificate through OHSAS 18001 our factory was also recognized as the first recipient of this certificate in Turkey.

PharmaVision also became the first company in Turkey to receive the SA 8000 Social Accountability Certificate in the beginning of 2000. Certificates of TS EN ISO 22000 Food Safety (Product Safety) Management System, TS ISO 31000 Risk Management System, TS EN 16001 Energy Management Systems, TS ISO/IEC 27001 Information Security Management System and TS EN ISO/IEC 17025 Laboratory Accreditation obtained by PharmaVision were each a first in the Turkish pharmaceutical industry and together with the Responsible Care® Program these systems constitute the backbone of the company’s management systems. Moreover, the “EU GMP Certificate” obtained following the EU GMP audit conducted by the French Health Products Safety Agency (AFSAPPS) in 2010, has proved to be a major step in fulfilling our production for export goals.
 

 

 

 
sep
  Zolaks Bilişim